Device for Marking Site of Breast Biopsy

When placed in the biopsy site, the device rapidly hydrates and conforms to the size and shape of the biopsy cavity. Within several weeks, the MammoMark resorbs, leaving the centrally placed clip for long-term follow-up. The device is echogenic and radiopaque, allowing doctors to easily and precisely identify the location of the biopsy by using ultrasound or mammography. The device is the product of Artemis Medical, Inc. (Hayward, CA, USA), which develops minimally invasive diagnostic and therapeutic options for cancer.

"The Artemis MammoMark offers several advantages over current marking devices,” said Dr. Laurie Fajardo, chief of breast imaging and intervention in the department of radiology at the Johns Hopkins Medical Institutions (Baltimore, MD, USA). "The MammoMark provides an improved means of locating the biopsy site using ultrasound
imaging, which other devices do not, as well as a means of centrally marking the biopsy site.”





Related Links:
Artemis